Lyell Immunopharma (LYEL) Property, Plant & Equipment (Net) (2020 - 2026)

Lyell Immunopharma (LYEL) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,831.58 Bn	66,831.30 Bn	-	642,333.36
2	Nanobiotix	1,916.61 Bn	1,916.55 Bn	-	5.32 Mn
3	Akari Therapeutics	976.78 Bn	976.78 Bn	-	-
4	BeOne Medicines	471.48 Bn	466.69 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.78 Bn	114.53 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.87 Bn	61.12 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	63.06 Bn	63.06 Bn	-	-
8	Argenx Se	55.78 Bn	50.60 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.54 Bn	34.53 Bn	959.66 Mn	518.26 Mn
10	Lyell Immunopharma	284.61 Mn	284.61 Mn	-	32.72 Mn

Download Data